Theme: Advanced Practices in Blood Cancer Treatment

Blood Cancer 2017

Blood Cancer 2017

Conference Series LLC is glad to welcome all the interested participants to its 7th International Conference on Blood Cancer and Treatment during May 25-27, 2017 at London, UK. The conference will be organized around the theme “Advanced Practices in Blood Cancer Treatment”. Blood Cancer 2017 welcomes the hematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Blood Cancer 2017 will be an initiative to find the weapon to fight against the dreadful blood cancers, to protect and save lives. Discussions will be focused on the different types of blood cancers, possibility of early detection and treatment at the advanced stages of these cancers to prolong life.

Track 1Blood Malignancies

Blood malignancies are forms of cancer that begins in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukaemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes. The other types of Blood Malignancies also include sarcoma, lymphodema, Non-Hodgkin lymphoma (NHL) and lymphoma, lymphoid cancer, bone marrow cancer.

 

Track 2: Leukemia

Leukemia is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Different kinds of leukemia are believed to have different causes. There are four main types of leukemia — acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML).Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues. It is the most common type of cancer in children, with three quarters of leukemia cases in children being ALL

 

Track 3: Myeloma

Myeloma is a cancer arising from plasma cells, a type of white blood cell which is made in the bone marrow. Unlike many cancers, myeloma does not exist as a lump or tumour. Myeloma can be of smoldering type & the common known as multiple myeloma. Myeloma affects multiple places in the body (hence ‘multiple’ myeloma) where bone marrow is normally active in an adult i.e. within the bones of the spine, skull, pelvis, the rib cage, long bones of the arms and legs and the areas around the shoulders and hips. Myeloma is a relapsing-remitting cancer.

 

Track 4: Myelodysplastic Syndrome

The myelodysplastic syndromes (also known as MDS or myelodysplasia) are haematological medical conditions with ineffective production of all blood cells. In some cases, the disease worsens and the patient develops low blood counts caused by progressive bone marrow failure. The myelodysplastic syndromes are all disorders of the hematopoietic stem cells in the bone marrow. In MDS, blood production is disorderly and ineffective. The number and quality of blood-forming cells decline irreversibly, further impairing blood production. In this section detailed information about myelodysplastic syndromes will be discussed.

 

Track 5: Childhood Hematological Cancers

Childhood blood cancers are rare. The major subtypes of childhood blood cancers are lymphoblastic, Burkitt, large B cell & anaplastic large cell. Treatment at special centres for children and teens provides the advantages of specialized care. In addition, childhood cancers tend to respond to treatment better than adult cancers do, and children's bodies often tolerate treatment better. Treatment may involve antibiotics, blood transfusions, or other measures to fight infection. In this section, we will be discussing about the various types of childhood blood cancers, symptoms included, their diagnosis & treatment options available.

Track 6: Blood Cancer: Diagnosis

To confirm the presence of cancer and the severity or the stages of the cancer various cancer detection tests are carried out; certain cancer blood tests or other laboratory tests, such as an analysis of your urine or a biopsy of a suspicious area, to help guide the diagnosis. With the exception of blood cancers, blood tests generally can't absolutely tell cancer or some other noncancerous condition, but they can give your doctor the clues about what's going on inside the body. The other kind of tests performed to diagnose or confirm blood cancer can also include complete blood count and Blood protein testing, Tumour marker tests and Biopsy, Cytogenetic, Imaging and Radiation Oncology, Endoscopy.

 

Track 7: Blood Cancer : Causes & Symptoms

The cause is usually different from other types of cancer. Experts say that Blood Malignancies arise due to different causes, some of them are suspected and some are yet to be. It is nearly impossible to prove what caused a blood cancer in any individual, because most blood cancers have multiple possible causes.

Discussions will be carried out on the suspecting and suspected causes of blood cancer that include: Exposure to radiation and chemicals, Genetic predisposition, drugs, Human T-cell Leukemia Virus (HTLV), Electromagnetic energy, Genetic factors (chromosomal abnormalities, maternal fetal transmission (rare).

 

Track 8: Blood Cancer: Staging

Staging is the process of determining the extent to which a cancer has developed by spreading. Contemporary practice is to assign a number from I-IV to a blood cancer, with I being an isolated cancer and IV being a cancer which has spread to the limit of what the assessment measures. The stage generally takes into account the size of a tumor, whether it has invaded adjacent organs, how many regions it has spread to, and whether it has appeared in more distant locations .There are different yards sticks to distinguish blood cancer into different stages according to the symptoms of prognosis and rate of metastasis. In this section discussions will be carried out on different stages of various blood cancers.

 

Track 9: Blood Cancer: Treatment and Care

Treatment depends on many factors, including the type of cancer; age; how fast the cancer is progressing; where the cancer has spread; the symptoms and other health conditions. According to one of the most recent findings, researchers have come up with a curative alternative to blood cancer. The medication seeks to block the release of irregular enzymes accountable for the metastasis of blood cancer that are various therapies. Surfeit of protein accountable for the enlargement and increase of cancerous cells are likely to be blocked as well by the researched medication.

Different types of therapies such as Biological Therapy, Chemotherapy, Radiation Therapy, Bone Marrow Transplantation,
Stem Cell Transplantation, Targeted Therapy, Watchful Waiting,  Clinical medicine and anticancer drugs, Gene therapy and Stem cells therapy will be discussed in this scientific session.

 

Track 10: Bone Marrow Transplantation & Surgery

A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Bone marrow is the soft, fatty tissue inside your bones. Stem cells are immature cells in the bone marrow that give rise to all of your blood cells. A biopsy is a sample of tissue taken from the body in order to examine it more closely. A doctor should recommend a biopsy when an initial test suggests that an area of tissue in the body isn't normal. Doctors may call that area of abnormal tissue a lesion, a tumour, or a mass.Topics of discussion in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations

 

Track 11:  Immunology of Blood Cancer

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumour marker-based diagnostic tests. These scientific sessions will include the discussion on various topics such as Immunotherapeutic approaches, immune tolerance and deficiencies, Anti-Blood Cancer Factor and immunotherapy.

 

Track 12: Blood Oncology

Many Advanced approaches to treat patients with blood cancer. Developments in personalized treatment are taken into account the type, location, and stage of the disease as well as the patient's age and physical health. Chemotherapy is the primary treatment for blood cancer, though some patients receive radiation therapy as well and/or a transplant of stem cells or bone marrow. According to studies, antioxidants like lymohotoxins can also reduce the risk of one suffering from Blood Malignancies.

Major discussions will be carried out on Molecular Pathogenesis and Personalized Treatment, Epidemiology of Blood Cancer ,Blood Cancer Awareness and Society, Alternate Cancer therapy, Prevention of blood cancer, Importance of Antioxidants.      

 

Track 13: Hematological Malignancies: Prognosis

The estimate of how the disease will go for a patient is called prognosis. There are many factors affect prognosis that include: the type of cancer and where it is in the body, the stage of the cancer, the cancer’s grade. Grade provides clues about how quickly the cancer is likely to grow and spread certain traits of the cancer cells, the age and how healthy body was before cancer & how successful is the treatment.

 

Track 14: Blood Cancer : Other Aspects

Other features that are related to blood cancer include several other factors. Anaemia is a common side effect of chemotherapy procedures & sometimes blood cancer itself is cause of anaemia. Researches have shown that there is a clear connection between blood cancer and thrombosis, because some of the genetic changes that cause blood cancer also increase the activation of clotting factors. People with cancer are at increased risk of developing these dangerous blood clots. The other risk factors include blood transfusions, lymphatic System defects, exposure to radiation and carcinogenic chemicals.

Socio economic factors &  also serve to play a role in Blood Cancer. Some syndromes that are caused by genetic mutations (abnormal changes) present at birth seem to raise the risk of Blood Cancer.

 

Blood Cancer 2016

The success of the Blood Cancer 2016 conference has given us the prospect to bring the gathering one more time. OMICS International along with its subsidiary Conference Series LLC hosted the “4th International Conference on Blood Malignancies & Treatment” duringApril 18-19, 2016, at The Oberoi, Dubai, UAE

The conference was focused on Blood Cancer and Treatment Research studies with the theme “Conquering blood cancer with contemporary precision therapeutics and restorative approaches”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like Blood Malignancies, Leukemia, Myeloma, Childhood Hematological Cancers , Blood Cancer : Treatment & Care, Blood Cancer Diagnosis, Blood Cancer : Causes & Symptoms, Bone Marrow Transplantation & Surgery, Blood Cancer : Other Aspects.

The conference was embarked with an opening ceremony followed by Speaker sessions and followed by series of lectures delivered by both Honorable Guests and speakers. The adepts who promulgated the theme with their exquisite talk were:

·         Dr. John Batchelor, Central Manchester Foundation Trust, UK

·         Dr. Jean Jacques Fournié, Cancer Research Center of Toulouse, France

·         Dr. Elena Zakharova, Botkin Memorial Teaching Hospital, Russia

·         Dr. Ashutosh Wechalekar, University College London, UK

·         Dr. Michael Keng, University of Virginia, USA

·         Dr. Inga Mandac Rogulj, Clinical Hospital Merkur, Croatia

 

Best YRF Awardees:

Areeg Bala Elbahsire Moahmed Ahmed: King Abdulaziz Hospital-Al Ahsa, KSA

Talal Hussein Alshareef: King Saud bin Abdulaziz University for Health Sciences, KSA

 

Best Poster Awardees:

Amani Mahbub, Umm Al Qura University, Saudi Arabia

OMICS International offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with OMICS International and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Blood Cancer-2016, OMICS International would like to announce the commencement of the “7thInternational Conference on Blood Cancer & Treatment” to be held during May 25-27, 2016at London, UK. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Blood Cancer Research.

For More details:  http://bloodmalignancies.conferenceseries.com/

Let us meet again @ Blood Cancer 2017


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date May 25-27, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
bloodcancer@insightconferences.com
Sponsors / Exhibiting / Advertising.
bloodcancer@conferenceseries.net
General Queries.
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.